EUVIMEDEUVIMED entdecken
Crossref

PET imaging of synaptic vesicle glycoprotein 2 subtype A for neurological recovery in ischemic stroke

Xiaoyun Luo, Chentao Jin, Hetian Chen, Jiaqi Niu, Congcong Yu, Xiaofeng Dou, Jing Wang, Junjie Wen, Hong Zhang iD, Mei Tian, Yan Zhong

European Journal of Nuclear Medicine and Molecular Imaging · 2024

DOI: 10.1007/s00259-024-06904-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Xiaoyun Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Z…. Hauptthemen laut MEDLINE: Rats, Sprague-Dawley, Ischemic Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Ministry of Science and Technology of China (MOST), National Natural Science Foundation of China (NSFC), Zhejiang Provincial Key Research and Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: [18F]SynVesT-1 is a novel radiopharmaceutical for assessing synaptic density in vivo. This study aims to investigate the potential of [18F]SynVesT-1 positron emission tomography (PET) in evaluating neurological recovery in the rat model of ischemic stroke, and to compare its performance with [18F]FDG PET. METHODS: Sprague-Dawley rats were subjected to photothrombotic cerebral infarction, and safinamide was administered intraperitoneally from day 3 to day 14 post-stroke to alleviate neurological deficits. Cylinder test and forelimb placing test were performed to assess the neurological function. MRI, [18F]SynVesT-1 PET/CT and [18F]FDG PET/CT imaging were used to evaluate infarct volume, synaptic density, and cerebral glucose metabolism pre- and post-treatment. [18F]SynVesT-1 and [18F]FDG PET images were compared using Statistical Parametric Mapping (SPM) and region of interest (ROI)-based analysis. Post-mortem histological analysis was performed to validate PET images. RESULTS: Safinamide treatment improved behavioral outcomes in stroke-damaged rats. Both [18F]SynVesT-1 and [18F]FDG PET detected stroke-induced injury, with the injured region being significantly larger in [18F]FDG PET than in [18F]SynVesT-1 PET. Compared with the saline group, radiotracer uptake in the injured area significantly increased in [18F]SynVesT-1 PET after safinamide treatment, whereas no notable change was observed in [18F]FDG PET. Additionally, [18F]SynVesT-1 PET imaging showed a better correlation with neurological function recovery than [18F]FDG PET. Post-mortem analysis revealed increased neuronal numbers, synaptic density, and synaptic neuroplasticity, as well as decreased glia activation in the stroke-injured area after treatment. CONCLUSION: [18F]SynVesT-1 PET effectively quantified spatiotemporal dynamics of synaptic density in the rat model of stroke, and showed different capabilities in detecting stroke injury and neurological recovery compared with [18F]FDG PET. The utilization of [18F]SynVesT-1 PET holds promise as a potential non-invasive biomarker for evaluating ischemic stroke in conjunction with [18F]FDG PET.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rats, Sprague-DawleyIschemic StrokeAnimalsRatsMalePositron-Emission TomographyNerve Tissue ProteinsRecovery of FunctionMembrane GlycoproteinsPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

Positron emission tomography (PET)StrokeSynaptic densitySynaptic vesicle glycoprotein 2A

Substanzen

Nerve Tissue ProteinsSv2a protein, ratMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China.
  • Institute of Nuclear Medicine and Molecular, Imaging of Zhejiang University, Hangzhou, Zhejiang, 310009, China.
  • Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
  • Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University, Hangzhou, Zhejiang, 310014, China.
  • College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, Zhejiang, 310014, China.
  • Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China. hzhang21@zju.edu.cn.

ORCID-Profile: Hong Zhang

Förderung

  • Ministry of Science and Technology of China (MOST)
  • National Natural Science Foundation of China (NSFC)
  • Zhejiang Provincial Key Research and Development Plan

Zitieren

APA

Luo, X., Jin, C., Chen, H., Niu, J., Yu, C., Dou, X., Wang, J., Wen, J., Zhang, H., Tian, M., & Zhong, Y. (2024). PET imaging of synaptic vesicle glycoprotein 2 subtype A for neurological recovery in ischemic stroke. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06904-6

Vancouver

Luo X, Jin C, Chen H, Niu J, Yu C, Dou X, et al. PET imaging of synaptic vesicle glycoprotein 2 subtype A for neurological recovery in ischemic stroke. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06904-6

BibTeX
@article{Luo2024,
  author = {Luo, Xiaoyun and Jin, Chentao and Chen, Hetian and Niu, Jiaqi and Yu, Congcong and Dou, Xiaofeng and Wang, Jing and Wen, Junjie and Zhang, Hong and Tian, Mei and Zhong, Yan},
  title = {PET imaging of synaptic vesicle glycoprotein 2 subtype A for neurological recovery in ischemic stroke},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  doi = {10.1007/s00259-024-06904-6}
}
Kostenlos starten →